Recent advances in extracellular vesicle research for urological cancers: From technology to application

作者: Liang Dong , Richard C. Zieren , Yanqing Wang , Theo M. de Reijke , Wei Xue

DOI: 10.1016/J.BBCAN.2019.01.008

关键词:

摘要: Urological malignancies, including prostate cancer, bladder cancer and kidney are major causes of morbidity mortality worldwide. Because the high incidence, diversity in biology, especially direct interaction with urine, urological cancers an important resource for both scientists clinicians novel diagnostic therapeutic discovery. Extracellular vesicles (EVs) lipid bilayer encapsulated particles released by cells into extracellular space. Since EVs work as a safe way to transport biological information through whole body, they now recognized mechanism cell-cell communication have opened new window us gain better understanding diagnostics, options. In recent years, numerous evolutions EV technologies clinical findings continue be reported research field cancers. This comprehensive review aims give update advances summarize state-of-the-art knowledge related particularly focusing on potential biomarkers their roles promoting metastasis.

参考文章(283)
Jennifer N Wu, Kari M Fish, Christopher P Evans, Ralph W deVere White, Marc A Dall'Era, None, No improvement noted in overall or cause‐specific survival for men presenting with metastatic prostate cancer over a 20‐year period Cancer. ,vol. 120, pp. 818- 823 ,(2014) , 10.1002/CNCR.28485
Scott A. Tomlins, John R. Day, Robert J. Lonigro, Daniel H. Hovelson, Javed Siddiqui, L. Priya Kunju, Rodney L. Dunn, Sarah Meyer, Petrea Hodge, Jack Groskopf, John T. Wei, Arul M. Chinnaiyan, Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment European Urology. ,vol. 70, pp. 45- 53 ,(2016) , 10.1016/J.EURURO.2015.04.039
Mustafa Işın, Ege Uysaler, Emre Özgür, Hikmet Köseoğlu, Öner Şanlı, Ömer B. Yücel, Uğur Gezer, Nejat Dalay, Exosomal lncRNA-p21 levels may help to distinguish prostate cancer from benign disease Frontiers in Genetics. ,vol. 6, pp. 168- 168 ,(2015) , 10.3389/FGENE.2015.00168
Keishi Adachi, Koji Tamada, Immune checkpoint blockade opens an avenue of cancer immunotherapy with a potent clinical efficacy Cancer Science. ,vol. 106, pp. 945- 950 ,(2015) , 10.1111/CAS.12695
Diederick Duijvesz, C. Yin L. Versluis, Christa A.M. van der Fels, Mirella S. Vredenbregt-van den Berg, Janne Leivo, Mari T. Peltola, Chris H. Bangma, Kim S.I. Pettersson, Guido Jenster, Immuno-based detection of extracellular vesicles in urine as diagnostic marker for prostate cancer. International Journal of Cancer. ,vol. 137, pp. 2869- 2878 ,(2015) , 10.1002/IJC.29664
Taku Kato, Kosuke Mizutani, Koji Kameyama, Kyojiro Kawakami, Yasunori Fujita, Keita Nakane, Yusuke Kanimoto, Hidetoshi Ehara, Hiroyasu Ito, Mitsuru Seishima, Takashi Deguchi, Masafumi Ito, Serum exosomal P-glycoprotein is a potential marker to diagnose docetaxel resistance and select a taxoid for patients with prostate cancer Urologic Oncology-seminars and Original Investigations. ,vol. 33, pp. 385- ,(2015) , 10.1016/J.UROLONC.2015.04.019
T Suzuki, S Inoue, W Kawabata, J Akahira, T Moriya, F Tsuchiya, S Ogawa, M Muramatsu, H Sasano, EBAG9/RCAS1 in human breast carcinoma: a possible factor in endocrine-immune interactions. British Journal of Cancer. ,vol. 85, pp. 1731- 1737 ,(2001) , 10.1054/BJOC.2001.2176
Heikki Saari, Elisa Lázaro-Ibáñez, Tapani Viitala, Elina Vuorimaa-Laukkanen, Pia Siljander, Marjo Yliperttula, None, Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells. Journal of Controlled Release. ,vol. 220, pp. 727- 737 ,(2015) , 10.1016/J.JCONREL.2015.09.031
Shivakumar Keerthikumar, David Chisanga, Dinuka Ariyaratne, Haidar Al Saffar, Sushma Anand, Kening Zhao, Monisha Samuel, Mohashin Pathan, Markandeya Jois, Naveen Chilamkurti, Lahiru Gangoda, Suresh Mathivanan, ExoCarta: A Web-Based Compendium of Exosomal Cargo Journal of Molecular Biology. ,vol. 428, pp. 688- 692 ,(2016) , 10.1016/J.JMB.2015.09.019